Presentation Information
[P-40]Construction of an In Vivo Drug Efficacy Model for Anti-HBV Compounds Using HBV-Producing Cells in TK-NOG Mice
*Haruyo Aoyagi1, Yutaka Furutani2, Kousho Wakae1, Kenji Ogawa3, Takashi Niwa4, Kaoru Kobayashi5, Takamitsu Hosoya6, Yousuke Kanayama7, Yuichiro Higuchi8, Hiroshi Suemizu8, Sumiko Nashi Nagoshi9, Tomokazu Matsuura2, Yasuyoshi Watanabe10, Masanori Isogawa1, Takaji Wakita1, Hideki Aizaki1 (1. Japan Institute for Health Security, 2. The Jikei University school of medicine, 3. Nihon University, 4. Kyushu University, 5. Meiji Pharmaceutical University, 6. Institute of Science Tokyo, 7. RIKEN Nishina Center for Accelerator-Based Science, 8. Central Institute for Experimental Medicine and Life Science, 9. Saitama Medical University, 10. RIKEN Center for Biosystems Dynamics Research)